Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.700 | None | 0.899 | 12 | 1 | 2004 | 2019 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.500 | None | 0.889 | 7 | 8 | 2000 | 2019 | ||||||||
|
C-C motif chemokine receptor 6 | 0.485 | 0.808 | 5.8E-03 |
|
disease | 0.500 | None | 1.000 | 7 | 5 | 2001 | 2019 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.500 | None | 0.848 | 6 | 3 | 2002 | 2019 | ||||||||
|
peptidyl arginine deiminase 4 | 0.494 | 0.808 | 4.6E-16 |
|
disease | 0.500 | None | 0.912 | 6 | 4 | 2003 | 2020 | ||||||||
|
interferon regulatory factor 5 | 0.489 | 0.731 | 9.0E-03 |
|
disease | 0.500 | None | 0.906 | 4 | 3 | 2006 | 2019 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 1.000 | 4 | 2 | 1992 | 2019 | ||||||||
|
interleukin 6 receptor | 0.471 | 0.846 | 3.2E-05 |
|
disease | 0.500 | None | 0.971 | 4 | 2 | 2001 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.936 | 3 | 2 | 1989 | 2020 | ||||||||
|
TNF receptor associated factor 1 | 0.554 | 0.731 | 3.6E-03 |
|
disease | 0.500 | None | 0.850 | 3 | 2 | 2007 | 2019 | ||||||||
|
Fc fragment of IgG receptor IIa | 0.480 | 0.769 | 2.0E-06 |
|
disease | 0.500 | None | 0.852 | 1 | 1 | 2002 | 2020 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.490 | None | 1.000 | 5 | 2 | 2007 | 2019 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.490 | None | 0.786 | 5 | 2 | 2003 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 2 | 0.538 | 0.692 | 1.00 |
|
disease | 0.490 | None | 1.000 | 5 | 3 | 2012 | 2019 | ||||||||
|
interleukin 2 receptor subunit beta | 0.491 | 0.846 | 0.29 |
|
disease | 0.470 | None | 0.909 | 3 | 2 | 1992 | 2019 | ||||||||
|
REL proto-oncogene, NF-kB subunit | 0.579 | 0.692 | 1.00 |
|
disease | 0.460 | None | 0.909 | 5 | 2 | 2009 | 2019 | ||||||||
|
AF4/FMR2 family member 3 | 0.623 | 0.692 | 1.00 |
|
disease | 0.460 | None | 1.000 | 5 | 5 | 2009 | 2016 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
disease | 0.460 | None | 1.000 | 1 | 1 | 2009 | 2016 | ||||||||
|
membrane metalloendopeptidase like 1 | 0.606 | 0.692 | 1.2E-22 |
|
disease | 0.440 | None | 0.909 | 7 | 4 | 2008 | 2019 | ||||||||
|
ankyrin repeat domain 55 | 0.650 | 0.462 | 6.8E-08 |
|
disease | 0.440 | None | 1.000 | 6 | 3 | 2010 | 2019 | ||||||||
|
cyclin dependent kinase 6 | 0.471 | 0.731 | 0.98 |
|
disease | 0.440 | None | 0.714 | 2 | 1 | 2008 | 2019 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.430 | None | 1.000 | 4 | 3 | 2005 | 2019 | ||||||||
|
NFKB inhibitor epsilon | 0.700 | 0.385 | 0.77 |
|
disease | 0.420 | None | 1.000 | 2 | 2 | 2012 | 2016 | ||||||||
|
AT-rich interaction domain 5B | 0.638 | 0.500 | 1.00 |
|
disease | 0.410 | None | 1.000 | 5 | 3 | 2012 | 2019 | ||||||||
|
deoxyribonuclease 1 like 3 | 0.575 | 0.769 | 3.0E-05 |
|
disease | 0.410 | None | 1.000 | 2 | 1 | 2012 | 2019 |